Kirin Antigen definition

Kirin Antigen means an antigen that is claimed by a patent or is otherwise covered by intellectual property rights that are Controlled by Kirin.

Examples of Kirin Antigen in a sentence

  • Dendreon and its Affiliates shall not use Kirin Antigen for any purpose other than those purposes permitted in this Agreement, the Collaborative License Agreement or the Research and License Agreement.

  • The foregoing license grant shall apply in countries where there is a patent or other intellectual property right Controlled by Kirin covering such Kirin Antigen.

  • Sexual violence and other types of sexual misconduct have no place in a learning or work environment.

  • Thereafter, but only during the period when Purchaser is permitted hereunder to exercise the Back-Up License, Purchaser shall be permitted access to and a right of reference to any Regulatory Approvals held in Supplier's name for the Kirin Antigen or Dendreon Antigen that is the subject of such Back-Up License.

  • Supplier shall commit to Purchaser a co-exclusive license as to Kirin Antigen or.

  • Dendreon and its Affiliates shall not use Kirin Antigen for any purpose other than those purposes permitted in this Agreement, the License Agreement or the Research and License Agreement.

  • To the extent consistent with the rights retained or exercised by the ROFR Party, Kirin may exercise such Kirin Antigen Semi-Exclusive Commercial License or Kirin Antigen Non-Exclusive Commercial License, as the case may be, with respect to such Antigen.

  • If, despite good faith efforts, the senior management officials are unable to reach agreement on the resolution of such supply problem within twenty (20) days of their commencing such discussions, then at either Party's immediate written request, the problem will be governed by the terms of Section 11.7 if it affects Components other than Kirin Antigen or Dendreon Antigen, and by the terms of Section 3.7(c) if it affects Kirin Antigen or Dendreon Antigen.

Related to Kirin Antigen

  • Antigen means a substance recognized by the body as being foreign; it results in the production of specific antibodies directed against it.

  • Licensed Compound means [***].

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Lead Compound means any compound of lead other than galena which, when treated in the manner described below, yields to an aqueous solution of hydrochloric acid a quantity soluble lead compound exceeding, when calculated as lead monoxide, five percent of the dry weight of the portion taken analysis.

  • Antibody means a molecule comprising or containing one or more immunoglobulin variable domains or any fragments, derivatives, variants or modifications thereof that bind to the same antigen.

  • Collaboration Target means the Initial Collaboration Targets set forth on Exhibit F and any Additional Target or Substitute Target that is selected in accordance with Section 3.3 of this Agreement.

  • Licensed Compounds means: (a) Research Program Active Compounds; (b) Novartis Active Compounds; (c) salts, hydrates, solvates, esters, metabolites, intermediates, stereoisomers and polymorphs of Research Program Active Compounds or Novartis Active Compounds; and (d) prodrugs of Research Program Active Compounds or Novartis Active Compounds (any of the foregoing, a “Licensed Compound”).

  • Development Candidate means a Compound that meets the Development Candidate Criteria for the initiation of a Development Program for the treatment of CF, and which is the subject of a notice from Vertex to CFFT that Vertex intends to commence formal pre-clinical development of the Compound in the Field pursuant to the provisions of Section 3.1 hereof.

  • Back-Up Compound means, with reference to any particular Development Candidate or Drug Product Candidate, a Compound which (a) has the same principal mode of action (i.e., Potentiator or Corrector) as that Development Candidate or Drug Product Candidate; and (b) was among the group of Compounds, identified by VERTEX as potential additional lead molecules having the same principal mode of action, from which the Development Candidate was selected.

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.

  • Collaborating physician means the physician who,

  • Product Candidate means any pharmaceutical product developed, manufactured and/or tested by or on behalf of the Company that has not received a Regulatory Authorization for commercial distribution other than in connection with pre-clinical or clinical trials.

  • Biosimilar Product means, with respect to a Licensed Product and on a country-by-country basis, a product that [***].

  • Opioid antagonist means a drug that binds to opioid

  • Diagnostic Product means any test or assay for diagnosing or detecting a disease, disorder, medical condition, or symptom.

  • Gene Therapy means the introduction of a nucleic acid sequence encoding a protein intended for or otherwise conferring therapeutic benefit into a person for therapeutic purposes (i) by in vivo introduction for incorporation into cells of such person, or (ii) by ex vivo introduction into cells for transfer into a person.

  • BMS means the Company, all related companies, affiliates, subsidiaries, parents, successors, assigns and all organizations acquired by the foregoing.

  • Aerosol coating product means a pressurized coating product containing pigments or resins that dispenses product ingredients by means of a propellant, and is packaged in a disposable can for hand-held application, or for use in specialized equipment for ground traffic/marking applications.

  • GSK has the meaning set forth in the preamble.

  • hit means the existence of a match or matches established by the Central System by comparison between biometric […] data recorded in the computerised central database and those transmitted by a Member State with regard to a person, without prejudice to the requirement that Member States shall immediately check the results of the comparison pursuant to Article 26(4);

  • Compound means the taking of two or more ingredients and fabricating them into a single

  • Therapeutic school means a residential group living facility:

  • Biosimilar means a biological product that is highly similar to a specific reference biological

  • Collaborator An individual who is not under the direct supervision of the PI (e.g., not a member of the PI’s laboratory) who assists with the PI’s research project involving controlled-access data subject to the NIH GDS Policy. Internal collaborators are employees of the Requester and work at the same location/campus as the PI. External collaborators are not employees of the Requester and/or do not work at the same location as the PI, and consequently must be independently approved to access controlled-access data subject to the NIH GDS Policy.

  • Merck has the meaning set forth in the preamble.

  • Receptor means enclosed spaces, conduits, protected groundwater sources, drinking and non-drinking water wells, surface water bodies, and public water systems which when impacted by chemicals of concern may result in exposure to humans and aquatic life, explosive conditions or other adverse effects on health, safety and the environment as specified in these rules.